NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

$4.05
+0.07 (+1.76%)
(As of 05/3/2024 08:53 PM ET)
Today's Range
$3.99
$4.11
50-Day Range
$3.95
$5.16
52-Week Range
$3.92
$16.18
Volume
248,300 shs
Average Volume
378,820 shs
Market Capitalization
$85.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.25

PetMed Express MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
227.2% Upside
$13.25 Price Target
Short Interest
Bearish
22.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.72mentions of PetMed Express in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
900.00%
From $0.01 to $0.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.21 out of 5 stars

Retail/Wholesale Sector

107th out of 202 stocks

Drug Stores & Proprietary Stores Industry

3rd out of 4 stocks

PETS stock logo

About PetMed Express Stock (NASDAQ:PETS)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Stock Price History

PETS Stock News Headlines

41 banks launch ‘crypto dollar’
Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).
PetMed Express Names Sandra Campos President, CEO
Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Should you pay for pet insurance?
Is pet insurance worth it?
Petmed Express, Inc.
Will Walgreens (WBA) Go Bankrupt?
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/15/2024
Today
5/06/2024
Next Earnings (Estimated)
5/27/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
302
Year Founded
1996

Price Target and Rating

Average Stock Price Target
$13.25
High Stock Price Target
$20.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+227.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$5.14 million
Pretax Margin
-0.84%

Debt

Sales & Book Value

Annual Sales
$256.86 million
Cash Flow
$0.53 per share
Book Value
$5.22 per share

Miscellaneous

Free Float
20,388,000
Market Cap
$85.66 million
Optionable
Optionable
Beta
0.73

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

PETS Stock Analysis - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price target for 2024?

2 Wall Street research analysts have issued 12-month target prices for PetMed Express' stock. Their PETS share price targets range from $6.50 to $20.00. On average, they expect the company's stock price to reach $13.25 in the next year. This suggests a possible upside of 227.2% from the stock's current price.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2024?

PetMed Express' stock was trading at $7.56 on January 1st, 2024. Since then, PETS shares have decreased by 46.4% and is now trading at $4.05.
View the best growth stocks for 2024 here
.

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our PETS earnings forecast
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its earnings results on Monday, April, 15th. The company reported ($0.10) earnings per share for the quarter. The company earned $65.32 million during the quarter. PetMed Express had a negative net margin of 2.92% and a negative trailing twelve-month return on equity of 1.25%.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express declared a quarterly dividend on Monday, July 31st. Stockholders of record on Monday, August 14th will be paid a dividend of $0.30 per share on Friday, August 18th. This represents a $1.20 dividend on an annualized basis and a yield of 29.63%. The ex-dividend date of this dividend is Friday, August 11th.
Read our dividend analysis for PETS
.

What guidance has PetMed Express issued on next quarter's earnings?

PetMed Express updated its third quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $65.3 million-$65.3 million, compared to the consensus revenue estimate of $68.0 million.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (3.31%), Profit Investment Management LLC (0.46%), BNP Paribas Financial Markets (0.31%), HTLF Bank (0.29%) and Oak Thistle LLC (0.05%). Insiders that own company stock include Bruce S Rosenbloom, Christine Chambers, Gian Fulgoni and Mathew N Hulett.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PETS) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners